Wang Scarlett Sijia, Akee Randall, Simeonova Emilia, Glied Sherry
Robert F. Wagner Graduate School of Public Service, New York University, New York, New York, USA.
Luskin School of Public Affairs, University of California, Los Angeles, California, USA.
Health Serv Res. 2025 Feb;60(1):e14389. doi: 10.1111/1475-6773.14389. Epub 2024 Oct 10.
To understand why American Indian and Alaskan Native (AIAN) populations have had exceptionally high COVID-19 mortality, we compare patterns of healthcare utilization and outcomes for two serious infectious respiratory diseases-Influenza-like-illness (ILI) and coronavirus disease 2019 (COVID-19)-between American Indian and Alaskan Native (AIAN) populations (as identified in Medicaid data) and non-Hispanic Whites over the 2009-2021 period.
We select all people under the age of 65 years identified as non-Hispanic White or AIAN in the New York State Medicaid claims data between 2009 and 2021. We analyze data across 10 ILI cohorts (between September 2009 and August 2020) and 4 COVID-19 cohorts (March-June 2020, July-September 2020, October-December 2020, and January-June 2021). We examine mortality and utilization rates using logistic regressions, adjusting for demographic characteristics, prior chronic conditions, and geographic location (including residence near a reservation). We stratify the analysis by rural vs. nonrural counties.
We use the New York State Medicaid claims data for the analysis.
We find that even among Medicaid beneficiaries, who are similar in socioeconomic status and identical in health insurance coverage, AIAN populations have much lower rates of use of outpatient services and much higher rates of acute (inpatient and emergency room) service utilization for both ILI and COVID-19 than non-Hispanic Whites. Prior to COVID-19, demographic and health status-adjusted all-cause mortality rates, including from ILI, were lower among American Indians than among non-Hispanic Whites on New York State Medicaid, but this pattern reversed during the COVID-19 pandemic. Both findings are driven by nonrural counties. We did not observe significant differences in all-cause mortality and acute service utilization comparing AIAN to non-Hispanic Whites in rural areas.
The utilization and mortality disparities we identify within the Medicaid population highlight the need to move beyond insurance in addressing poor health outcomes in the American Indian population.
为了解为何美国印第安人和阿拉斯加原住民(AIAN)人群的新冠病毒病(COVID-19)死亡率异常高,我们比较了2009年至2021年期间美国印第安人和阿拉斯加原住民(根据医疗补助数据确定)与非西班牙裔白人在两种严重传染性呼吸道疾病——流感样疾病(ILI)和2019冠状病毒病(COVID-19)方面的医疗保健利用模式和结果。
我们从2009年至2021年纽约州医疗补助索赔数据中选取所有65岁以下被认定为非西班牙裔白人或AIAN的人群。我们分析了10个ILI队列(2009年9月至2020年8月)和4个COVID-19队列(2020年3月至6月、2020年7月至9月、2020年10月至12月以及2021年1月至6月)的数据。我们使用逻辑回归分析死亡率和利用率,并对人口统计学特征、既往慢性病状况和地理位置(包括保留地附近的居住情况)进行调整。我们按农村和非农村县对分析进行分层。
我们使用纽约州医疗补助索赔数据进行分析。
我们发现,即使在社会经济地位相似且医疗保险覆盖相同的医疗补助受益人群中,AIAN人群在ILI和COVID-19方面的门诊服务使用率远低于非西班牙裔白人,而急性(住院和急诊室)服务利用率则远高于非西班牙裔白人。在COVID-19之前,纽约州医疗补助计划中,经人口统计学和健康状况调整的全因死亡率,包括ILI导致的死亡率,美国印第安人低于非西班牙裔白人,但在COVID-19大流行期间这种模式发生了逆转。这两个发现都是由非农村县推动的。在农村地区,我们未观察到AIAN人群与非西班牙裔白人在全因死亡率和急性服务利用率方面存在显著差异。
我们在医疗补助人群中发现的利用和死亡率差异凸显了在解决美国印第安人群健康状况不佳问题时,不能仅局限于保险层面。